The immunogenetic basis for anti-neutrophil cytoplasmic antibody production in primary sclerosing cholangitis and ulcerative colitis. by Mehal, W, Lo, S, Chapman, R, Fleming, K

A survey of cytomegalovirus (CMV) DNA in primary sclerosing cholangitis (PSC) liver tissues using a sensitive polymerase chain reaction (PCR) based assay. by Mehal, W, Hattersley, A, Chapman, R, Fleming, K

ANTIBIOTIC-PROPHYLAXIS FOR ERCP - A RANDOMIZED CLINICAL-TRIAL OF CIPROFLOXACIN VERSUS CEFUROXIME by Mehal, W, Culshaw, K, Tillotson, G, Chapman, R

Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis. by Mehal, W, Culshaw, K, Tillotson, G, Chapman, R

HLA DRW52A AND DW2 ARE NOT ASSOCIATED WITH THE DEVELOPMENT OF ANTI NEUTROPHIL ANTIBODY TYPE1 (ANCA1) IN ULCERATIVE-COLITIS (UC) by Mehal, W, Lo, S, Wordsworth, P, Chapman, R, Fleming, K

OLIGONUCLEOTIDE DNA TYPING ANALYSIS OF THE HLA DRB3 LOCUS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC) by Mehal, W, Wordsworth, P, Bell, J, Fleming, K, Chapman, R

PROCOLLAGEN-III PEPTIDE AS AN INDICATOR OF HEPATIC FIBROGENESIS IN PRIMARY SCLEROSING CHOLANGITIS by Mehal, W, Snook, J, Rudenski, A, Kay, J, Chapman, R

COMPARISON OF THE 2 ALLELES ASSOCIATED WITH PRIMARY SCLEROSING CHOLANGITIS (PSC) USING COMPUTER MODELING BASED ON THE CLASS 1 CRYSTALLINE-STRUCTURE by Mehal, W, Driscoll, P, Smith, M, Chapman, R, Fleming, K

Detection of reactivation and size variation in the regulatory region of JC virus in brain tissue. by Mehal, W, Esiri, M, Lo, Y, Chapman, R, Fleming, K

IMMUNOGENETIC FACTORS IN THE CLINICAL COURSE OF PRIMARY SCLEROSING CHOLANGITIS (PSC) by Mehal, W, Hubscher, S, Wordsworth, B, Neuberger, J, Fleming, K, Chapman, R

INABILITY TO ATTRIBUTE SUSCEPTIBILITY TO PRIMARY SCLEROSING CHOLANGITIS TO SPECIFIC AMINO-ACID POSITIONS OF THE HLA-DRW52A ALLELE by Mehal, W, Wordsworth, B, Taylor, C, Bell, J, Fleming, K, Chapman, R

HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. by Mehal, W, Lo, Y, Wordsworth, B, Neuberger, J, Hubscher, S, Fleming, K, Chapman, R

HLA typing by double ARMS [34] by Lo, Y, Mehal, W, Wordsworth, B, Chapman, R, Fleming, K, Bell, J, Wainscoat, J

HLA typing by double ARMS. by Lo, Y, Mehal, W, Wordsworth, B, Chapman, R, Fleming, K, Bell, J, Wainscoat, J

Increased prevalence of Listeria monocytogenes in the faeces of patients receiving long-term H2-antagonists. by Cobb, C, Curtis, G, Bansi, D, Slade, E, Mehal, W, Mitchell, R, Chapman, R

COMPLEMENT C4B2 AND HLA DR8 GENOTYPING EXPLAINS THEIR KNOWN ASSOCIATIONS IN PBC by Mehal, W, Gregory, W, Cross, S, Fleming, K, Campbell, R, James, O, Bassendine, M, Chapman, R, Rosenberg, W

LOCALIZATION OF THE IMMUNOGENETIC SUSCEPTIBILITY IN PRIMARY BILIARY-CIRRHOSIS (PBC) by Mehal, W, Gregory, W, Cross, S, Fleming, K, Campbell, R, James, O, Bassendine, M, Chapman, R, Rosenberg, W

ANALYSIS OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENOTYPE IN PRIMARY BILIARY-CIRRHOSIS USING RFLP AND PCR by Gregory, W, Mehal, W, Daly, A, Dunn, A, Cavanagh, G, Chapman, R, Idle, J, James, O, Bassendine, M

Defining the immunogenetic susceptibility to primary biliary cirrhosis. by Mehal, W, Gregory, W, Lo, Y, Cross, S, Fleming, K, Bassendine, M, James, O, Campbell, R, Chapman, R, Rosenberg, WM

Primary biliary cirrhosis: contribution of HLA class II allele DR8. by Gregory, W, Mehal, W, Dunn, A, Cavanagh, G, Chapman, R, Fleming, K, Daly, A, Idle, JR, James, O, Bassendine, M